Medscape has a recent article that contains some information about the young-plasma trial for AD.

"Human Blood May Offer Fresh Approach for Dementia Treatment", July 27, 2017.

"The next step is to identify and then deliver only those proteins that drive function. The idea is to actually make protein therapeutics or peptides that will recapitulate that function. This ... would avoid the need for plasma donors."

http://search.medscape.com/search/?q...ntia Treatment

(If you are not already a Medscape member, you will need to sign up for a free account)